Physiological changes during pregnancy and their implications for pharmacological treatment

Area of Science:

• Pharmacology
• Obstetrics
• Developmental Toxicology

Background:

• Drug therapy during pregnancy presents complex challenges for clinicians.
• Limited data exists on embryonic/fetal toxicity and the specific contributions of maternal disease or drug exposure to adverse outcomes.
• Physiological changes during pregnancy, such as altered pharmacokinetics, can impact drug effects unpredictably.

Purpose of the Study:

• To highlight the critical considerations for prescribing medications to pregnant patients.
• To emphasize the importance of understanding drug behavior and fetal development during pregnancy.
• To guide physicians in making rational therapeutic decisions by evaluating available research.

Main Methods:

• Review of existing literature on drug pharmacokinetics and pharmacodynamics in pregnancy.
• Analysis of placental drug transfer mechanisms and fetal exposure.
• Examination of developmental vulnerabilities at different gestational stages.

Main Results:

• Most drugs readily cross the placenta, leading to significant fetal blood levels.
• The first trimester is critical for anatomical malformation, while the brain's development throughout pregnancy poses risks for subtle, delayed adverse effects.
• Physiological changes during pregnancy can alter drug metabolism and distribution.

Conclusions:

• Physicians must exercise caution when prescribing drugs during pregnancy, acknowledging incomplete safety data.
• Awareness of altered maternal pharmacokinetics and the placenta's permeability is essential.
• Understanding the differential vulnerability of the conceptus at various developmental stages aids in rational prescribing and risk assessment.